Xylazine (Tranq) in Fentanyl: Overdose Signs, Wound Warning Signs, and Why Naloxone Still Matters
Table of Contents
Xylazine, often called “tranq” or “tranq dope,” is a veterinary sedative that has moved into the illicit fentanyl supply. Most people who are exposed to it never chose it. It arrives mixed into powder sold as fentanyl or heroin, and it changes two things families and first responders need to understand: what an overdose looks like, and what happens to the skin of someone who uses repeatedly. This guide walks through both, in plain terms, along with the specific steps that make a difference.
What Xylazine Is and How It Ends Up in the Drug Supply
Xylazine is a non-opioid tranquilizer approved for use in animals, not people. According to the Centers for Disease Control and Prevention (CDC), it is added to drugs like fentanyl, heroin, and cocaine either to extend the effects or to add weight and street value. The National Institute on Drug Abuse (NIDA) notes that people most often use xylazine without knowing it, because it is mixed into other drugs, most frequently fentanyl.
The scale is not small. Per the CDC, the DEA has seized xylazine and fentanyl mixtures in 48 of 50 states, and DEA laboratory data found xylazine in approximately 23% of fentanyl powder and 7% of fentanyl pills seized in 2022. The White House Office of National Drug Control Policy declared fentanyl mixed with xylazine an emerging threat and released a national response plan on July 11, 2023.
For anyone using fentanyl in powder form, the practical takeaway is direct: you should assume xylazine may be present, even if you have never knowingly used it.
What Xylazine Does in the Body
Xylazine is not an opioid, so it acts on the body through a different route than fentanyl. When the two are combined, their effects stack. Federal health agencies describe several distinct effects:
- Deep sedation: Xylazine causes heavy, prolonged sedation that can last well beyond the opioid effect, leaving a person unresponsive for long stretches.
- Slowed breathing: It depresses breathing on its own, which compounds the respiratory depression fentanyl already causes.
- Low blood pressure and slow heart rate: Xylazine can drop blood pressure and heart rate to dangerously low levels, according to NIDA.
- Skin wounds: Repeated use is associated with open sores (ulcers) and abscesses that can become infected, sometimes appearing away from where a person injected.
- Withdrawal on top of withdrawal: The CDC lists severe withdrawal symptoms among xylazine’s risks, which can complicate opioid withdrawal for people who have been exposed to both.
How to Recognize an Overdose Involving Xylazine
From the outside, a fentanyl-and-xylazine overdose looks like an opioid overdose at first: the person is unresponsive or cannot be woken, breathing is slow, shallow, or has stopped, lips or fingertips may turn blue or gray, and there may be gurgling or snoring sounds. The difference families report noticing is what comes after naloxone. Because naloxone reverses only the opioid, a person may start breathing again but stay heavily sedated and hard to rouse.
That lingering sedation is not a sign that naloxone failed. It is a sign that something other than an opioid is on board, and that the person still needs emergency medical care.
What to Do Today: The Xylazine Overdose Response
Naloxone does not reverse xylazine, but the CDC still says to give it in any suspected overdose, because xylazine is usually mixed with fentanyl and naloxone will reverse the opioid part. After giving naloxone, call 911 and stay with the person, since xylazine’s sedation and breathing effects can continue after naloxone works. The CDC notes that first responders have found rescue breathing especially helpful with xylazine; for adults, that means tilting the head back, pinching the nose, giving two slow breaths, and then one breath every 5 seconds until the person breathes on their own or help arrives.
Turn this into a check you can run tonight:
- Find the naloxone. Know exactly where it is in your home, car, or bag, and check the expiration date printed on the box.
- Practice the rescue-breath count out loud. Two slow breaths, then one every 5 seconds. Saying it once before an emergency makes it easier to do during one.
- Learn the recovery position. If the person is breathing but sedated, roll them onto their side so they do not choke, and do not leave them alone.
- Know your legal protection. Good Samaritan laws exist in most states, including California, to protect people who call 911 during an overdose.
Do not try to “wake someone up” with cold water, ice, or slapping. These do not reverse an overdose and waste time that should go to naloxone, rescue breaths, and calling 911.
Xylazine Wounds: What They Look Like and Why They Matter
Xylazine-related wounds are one of the clearest outward signs that a person’s supply contains tranq. They often start as small blistered or discolored patches that can open into ulcers. Over time, untreated wounds may darken, widen, and develop dead tissue. Unlike typical injection-site abscesses, they can appear on areas of the body where the person did not inject.
Signs that a wound needs urgent medical attention include spreading redness or warmth, fever or chills, a foul smell, increasing pain, or tissue that turns black. Infected wounds can progress to serious bloodstream or bone infections, so they should be seen by a medical provider rather than managed only at home.
For families, wounds are often the detail that makes the situation visible. A loved one wearing long sleeves in warm weather, unexplained bandages, or a new reluctance to be seen in short sleeves are common things relatives describe noticing before a conversation about treatment happens.
Why Xylazine Changes the Withdrawal and Treatment Picture
This is where the clinical reality gets inconvenient. Standard urine drug screens do not test for xylazine, and standard fentanyl test strips do not detect it. That means a person can arrive at treatment with xylazine exposure that does not show up on intake testing at all. The only reliable way a treatment team learns about it is if the person or family says so, or if wounds and unusually heavy sedation point to it.
From an admissions perspective, three pieces of information change how a person’s first days are planned:
- Suspected tranq exposure: Withdrawal may include restlessness, anxiety, and discomfort that do not match a typical opioid withdrawal course, so clinicians need to know to watch for it.
- Any open wounds: Wound care needs to be arranged from day one, and some wounds require medical evaluation before or alongside residential care.
- Other sedatives in use: If a person also uses alcohol or benzodiazepines, withdrawal from those substances carries a risk of seizures and requires medical supervision. Stopping them abruptly at home is not safe.
The question to ask any program, including ours, is simple: “How do you handle suspected xylazine exposure and wound care during the first week?” A clear answer tells you a lot. You can reach our team at (877) 328-1968 to ask it directly.
Treatment and Recovery After Xylazine Exposure
There is no medication approved specifically to treat xylazine dependence. Treatment focuses on managing withdrawal symptoms safely, addressing the underlying opioid use disorder with evidence-based care, including FDA-approved medications for opioid use disorder where appropriate, and healing wounds. Structured residential treatment gives a person round-the-clock support during the period when withdrawal, wound care, and early recovery overlap.
Recovery from fentanyl and xylazine exposure is possible, and wounds can heal with consistent medical care once use stops. Our approach in Northern California is overseen by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, and combines clinical care with practical support for families. To learn more about how specific substances affect the body, see our guide to drug effects.
If someone you love is using fentanyl and you suspect tranq is involved, you do not need to have every answer before you call. Speak with our admissions team at (877) 328-1968, or contact the free, confidential SAMHSA National Helpline at 1-800-662-4357, available 24 hours a day.
If This Is an Emergency
If someone is unresponsive or not breathing normally, call 911 now, give naloxone if you have it, and begin rescue breathing. If you or someone you know is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.
Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Withdrawal from alcohol, benzodiazepines, and some other substances can be life-threatening and should only be managed under medical supervision.


